Laboratory News and Research

RSS

Simple device to treat sleep apnea may reduce diabetes risk

Using a simple device for eight hours a night to treat sleep apnea can help people with prediabetes improve their blood sugar levels and may reduce the risk of progressing to diabetes, according to a new study published online in the April 21, 2015, issue of the American Journal of Respiratory and Critical Care Medicine.

28 Apr 2015

UW develops new app to wirelessly test sleep apnea events using smartphone

Determining whether your snoring is merely annoying, or crosses the threshold into a life-threatening problem, isn't convenient or cheap.

28 Apr 2015

Hebrew University and Harvard researchers develop method to map circuitry of the brain

In new research published today by Nature Methods, scientists from the Hebrew University of Jerusalem and Harvard University have announced a "Neuronal Positioning System" (NPS) that maps the circuitry of the brain, similar to how a Global Positioning System (GPS) receiver triangulates one's location on the planet.

28 Apr 2015

Discovery of molecular reset button for internal body clock could help treat different disorders

An international team of scientists has discovered what amounts to a molecular reset button for our internal body clock. Their findings reveal a potential target to treat a range of disorders, from sleep disturbances to other behavioral, cognitive, and metabolic abnormalities, commonly associated with jet lag, shift work and exposure to light at night, as well as with neuropsychiatric conditions such as depression and autism.

28 Apr 2015

Multichannel Pipette accelerates sample screening and genotyping assays INTEGRA

INTEGRA has published a new customer video from the Institute of Clinical Chemistry research group at the Technical University of Munich (TUM), in which researcher Christina Thomas reviews how the VOYAGER multichannel pipette has accelerated their sample screening and genotyping assays.

From INTEGRA Biosciences 28 Apr 2015

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, discusses the significance of the strong effectiveness demonstrated by its anti-viral drug candidates in a lethal animal model of dermal herpes infection.

27 Apr 2015

Researchers show potential of stem cell-based therapy in treating brain-metastatic breast cancer

Investigators from Massachusetts General Hospital and the Harvard Stem Cell Institute have developed an imageable mouse model of brain-metastatic breast cancer and shown the potential of a stem-cell-based therapy to eliminate metastatic cells from the brain and prolong survival.

27 Apr 2015

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Ahmad M. Khalil, PhD, knew the odds were against him -- as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.

25 Apr 2015

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, Inc., a global leader in non-invasive genetic testing, and LifeLabs Medical Laboratory Services today announced a new agreement that gives LifeLabs the rights to perform non-invasive prenatal testing (NIPT) in Canada using Natera technology.

From Natera 25 Apr 2015

Porvair Previews New Microplate Products at ACHEMA

Visitors to ACHEMA 2015 have been invited by Porvair Sciences to Stand F44 in Halle 4.2 to see their expansive range of application optimised microplates and microplate equipment...

From Porvair Sciences Limited 24 Apr 2015

Oncologists publish review of advanced clinical treatments for pancreatic cancer

The oncologists Manuel Hidalgo, Director of the Clinical Research Programme of the Spanish National Cancer Research Centre, and Ignacio Garrido-Laguna, member of the Experimental Therapeutics Program at Huntsman Cancer Institute of the University of Utah (USA), have recently published a review of state-of-the-art clinical treatments for pancreatic cancer -- including the most current therapies and innovative research -- in the prestigious scientific journal Nature Reviews Clinical Oncology.

24 Apr 2015

Eppendorf launches mobile app

Eppendorf AG's new app offers a variety of useful aids for everyday laboratory work in addition to product information that has been optimized for mobile devices.

24 Apr 2015

Alnylam announces clinical data from patisiran Phase 2 OLE study for treatment of patients with FAP

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today initial 12-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) in patients with familial amyloidotic polyneuropathy (FAP).

24 Apr 2015

Exome sequencing helps identify link between environmental exposures and mutational patterns in HCC

A new study presented today at The International Liver Congress 2015 shows that by using genomic analyses to understand how and when carcinogenic mutations occur in patients with hepatocellular carcinoma (HCC), it is possible to identify specific molecular profiles. It is hoped that these molecular profiles will help identify which patients would benefit from specific anticancer treatments.

23 Apr 2015

Epigenetic processes influence children's later ability to learn and cognitive performance

Although it is now widely recognised that a poor start to life has long-term effects on a child's later ability to learn, the mechanisms by which the environment in early life affects later life chances are poorly understood.

23 Apr 2015

New brain mapping model could improve success rate of transcranial magnetic stimulation

Brain researchers from the Perelman School of Medicine at the University of Pennsylvania have developed a new brain mapping model which could improve the success rate of transcranial magnetic stimulation (TMS) in treating conditions including depression, neuropathic pain, and stroke.

23 Apr 2015

First evidence-based guideline released to ensure patient safety

Today, the College of American Pathologists and the National Society for Histotechnology released the first evidence-based guideline to ensure patient safety through the uniform labeling of paraffin blocks and slides.

23 Apr 2015

May issues of AGA's journals highlight important research updates on liver disease

The May issues of AGA's journals -- Clinical Gastroenterology and Hepatology and Gastroenterology -- highlight important research updates on the most deadly forms of liver disease.

23 Apr 2015

EKF launches next generation Hemo Control POC hemoglobin analyzer

The new Hemo Control offers enhanced on-board Data Management (DM) functions following upgrade with the DM ‘add pack’ if required at a later date.

From EKF Diagnostics 22 Apr 2015

Sysmex Inostics to offer OncoBEAM CLIA laboratory services in Germany, Austria and Switzerland

Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.

From Sysmex America, Inc. 22 Apr 2015

Laboratory News and Research

Simple device to treat sleep apnea may reduce diabetes risk

UW develops new app to wirelessly test sleep apnea events using smartphone

Hebrew University and Harvard researchers develop method to map circuitry of the brain

Discovery of molecular reset button for internal body clock could help treat different disorders

Multichannel Pipette accelerates sample screening and genotyping assays INTEGRA

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

Researchers show potential of stem cell-based therapy in treating brain-metastatic breast cancer

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Porvair Previews New Microplate Products at ACHEMA

Oncologists publish review of advanced clinical treatments for pancreatic cancer

Eppendorf launches mobile app

Alnylam announces clinical data from patisiran Phase 2 OLE study for treatment of patients with FAP

Exome sequencing helps identify link between environmental exposures and mutational patterns in HCC

Epigenetic processes influence children's later ability to learn and cognitive performance

New brain mapping model could improve success rate of transcranial magnetic stimulation

First evidence-based guideline released to ensure patient safety

May issues of AGA's journals highlight important research updates on liver disease

EKF launches next generation Hemo Control POC hemoglobin analyzer

Sysmex Inostics to offer OncoBEAM CLIA laboratory services in Germany, Austria and Switzerland

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics